3D Communications is preeminent in preparing pharmaceutical, biotech and device companies for regulatory meetings with the FDA, EMA, and other regulatory agencies. It has just announced that it will expand its healthcare globally.
Breaking News
A webinar on Regulatory And Procedural Aspects Of Applications For Type I Variations is released by EMA.
Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by India's GVK Biosciences, French watchdog ANSM said on Friday.
Subscribe to VCpost newsletter
Most Popular
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- Walmart Founder's Son Rob Walton to Step Down From Board
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
- JPMorgan CEO Warns of Economic Risks Amid Biden's 'Huge' Deficit Spending, Questions Likelihood of 'Soft Landing'
